文献速递生殖医学

精子供者中囊性纤维化携带者:CFTR基因完整分析与CFTR基因分型的比较

Carriers of cystic fibrosis among sperm donors: complete CFTR gene analysis versus CFTR genotyping.
PubMed 文献 · Fertil Steril · 2020-08-06

该描述性观察研究分析了西班牙一家私立中心2014年1月至2019年6月的935名精子供者,通过完整CFTR基因分析检测致病变异。17%的供者为至少一种CFTR致病变异携带者,共检出39种不同变异;常用的4种CFTR基因分型检测仅能检出其中4种(10.27%),22种(56.41%)任何分型检测均无法检出。作者建议将二代测序完整测序CFTR基因作为精子供者的筛查方法。

要点

  • 935名精子供者中17%携带至少一种CFTR致病变异,共检出39种不同变异。
  • 4种常用CFTR基因分型检测仅能检出39种变异中的4种(10.27%)。
  • 22种变异(56.41%)不能被任何所分析的分型检测检出。

核心结论

  • 研究结果显示使用基因分型检测与较高的生殖风险相关,因为与CFTR基因完整研究相比,这些分型板对囊性纤维化携带者的检出率更低。
  • 作者建议将二代测序完整测序CFTR基因作为精子供者囊性纤维化的筛查方法。

研究设计与样本

  • 描述性观察研究,纳入2014年1月至2019年6月西班牙一家私立中心的935名精子供者。
  • 干预:无;主要结局指标为CFTR基因中致病变异的存在。

主要发现

  • 17%的供者为至少1种CFTR致病变异携带者,共检出39种不同致病变异。
  • 所考虑的4种基因分型检测仅能检出39种变异中的4种(10.27%)。
  • 22种变异(56.41%)不能被任何基因分型检测检出。
  • 所分析的不同基因分型检测包含的CFTR基因致病变异差异很大,所有检测共有的变异不足50%。

关键数值与推荐

  • 4种常用CFTR基因分型检测仅检出39种致病变异中的4种(10.27%)。
  • 22种致病变异(56.41%)不能被任何所分析的分型检测检出。
  • 不同基因分型检测所含CFTR致病变异差异很大,共有变异不足50%。

临床怎么用

  • 作者建议将二代测序完整测序CFTR基因作为精子供者囊性纤维化的筛查方法。

局限性

  • 原文指出该研究并非基于一般人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the frequency of cystic fibrosis (CF) carriers among sperm donors in Spain studied through a complete analysis of the CFTR gene and to compare the results with those that would have been obtained by the 4 genotyping panels of the CFTR gene most commonly used as a carrier test in the context of assisted reproduction in our country. DESIGN: Descriptive observational study. SETTING: Private center. PATIENTS: Nine hundred thirty-five sperm donors, from January 2014 to June 2019. INTERVENTION: None. MAIN OUTCOME MEASURE: Presence of pathogenic variants in the CFTR gene. RESULTS: 17% of the donors were carriers of at least 1 pathogenic variant in CFTR, with 39 different pathogenic variants detected. Only 4 of these 39 variants (10.27%) would have been detected by the 4 genotyping tests considered, and 22 variants (56.41%) would not have been detected by any of the genotyping tests. The pathogenic variants of the CFTR gene included in the different genotyping tests analyzed vary widely, and <50% are common to all of them. CONCLUSIONS: Although the was not based in the general population, these results show that the use of genotyping tests is associated with a high reproductive risk, because the rate of detection of CF carriers was lower when these panels were applied, in comparison with the complete study of the CFTR gene. We recommend that complete sequencing of the CFTR gene by next-generation sequencing be performed as a screening method for CF in sperm donors.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Molina M, Yoldi A, Navas P, et al. Carriers of cystic fibrosis among sperm donors: complete CFTR gene analysis versus CFTR genotyping. Fertil Steril. 2020. PMID: 32773111. doi:10.1016/j.fertnstert.2020.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。